Burzynski Research Institute (BZYR) EPS (Basic) Growth (5y) (2015 - 2025)
Burzynski Research Institute (BZYR) EPS (Basic) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Burzynski Research Institute | 1.31 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 6.37% |
| Aug 31, 2025 | 4.30% |
| May 31, 2025 | 6.26% |
| Feb 28, 2025 | -0.59% |
| Nov 30, 2024 | 10.02% |
| Aug 31, 2024 | 6.56% |
| May 31, 2024 | 8.93% |
| Feb 29, 2024 | -1.00% |
| Nov 30, 2023 | 0.30% |
| Aug 31, 2023 | 9.97% |
| May 31, 2023 | 11.13% |
| Feb 28, 2023 | 7.79% |
| Nov 30, 2022 | 8.83% |
| Aug 31, 2022 | 12.70% |
| May 31, 2022 | 12.86% |
| Feb 28, 2022 | 13.35% |
| Nov 30, 2021 | 7.12% |
| Aug 31, 2021 | 10.97% |
| May 31, 2021 | 3.09% |
| Feb 28, 2021 | 17.88% |